During the last session, Longboard Pharmaceuticals Inc (NASDAQ:LBPH)’s traded shares were 0.82 million, with the beta value of the company hitting 1.22. At the end of the trading day, the stock’s price was $35.09, reflecting an intraday loss of -5.14% or -$1.9. The 52-week high for the LBPH share is $40.48, that puts it down -15.36 from that peak though still a striking 89.74% gain since the share price plummeted to a 52-week low of $3.60. The company’s market capitalization is $1.37B, and the average intraday trading volume over the past 10 days was 0.5 million shares, and the average trade volume was 549.26K shares over the past three months.
Longboard Pharmaceuticals Inc (LBPH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.12. LBPH has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Longboard Pharmaceuticals Inc (NASDAQ:LBPH) trade information
Longboard Pharmaceuticals Inc (LBPH) registered a -5.14% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -5.14% in intraday trading to $35.09, hitting a weekly high. The stock’s 5-day price performance is 6.82%, and it has moved by -8.52% in 30 days. Based on these gigs, the overall price performance for the year is 440.68%. The short interest in Longboard Pharmaceuticals Inc (NASDAQ:LBPH) is 4.47 million shares and it means that shorts have 4.96 day(s) to cover.
The consensus price target of analysts on Wall Street is $36, which implies an increase of 2.53% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $16 and $90 respectively. As a result, LBPH is trading at a discount of -156.48% off the target high and 54.4% off the low.
Longboard Pharmaceuticals Inc (LBPH) estimates and forecasts
Statistics show that Longboard Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. Longboard Pharmaceuticals Inc (LBPH) shares have gone up 81.63% during the last six months, with a year-to-date growth rate less than the industry average at 14.23% against 16.60.
While earnings are projected to return 12.67% in 2024.
Longboard Pharmaceuticals Inc (NASDAQ:LBPH)’s Major holders
Longboard Pharmaceuticals Inc insiders own 1.07% of total outstanding shares while institutional holders control 119.87%, with the float percentage being 121.16%. FMR LLC is the largest shareholder of the company, while 163.0 institutions own stock in it. As of 2024-03-31, the company held over 4.53 million shares (or 18.9138% of all shares), a total value of $97.74 million in shares.
The next largest institutional holding, with 3.35 million shares, is of CORMORANT ASSET MANAGEMENT, LP’s that is approximately 9.4931% of outstanding shares. At the market price on 2024-03-31, these shares were valued at $72.43 million.
